Zoetis Inc. vs Abbvie Inc.
ZTS vs ABBV — side-by-side comparison from reported financials. ZTS leads 7, ABBV leads 4 of 11 comparable metrics.
Zoetis Inc.
ZTS · Healthcare
$73.90+1.12%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ZTS | ABBV |
|---|---|---|
| Price | $73.90 | $276.43 |
| Market cap | $30.5B | $488B |
| Revenue (TTM) | $9.52B | $64.4B |
| Revenue growth | +5.4% | +1.8% |
| Net margin | 27.5% | 9.8% |
| Free cash flow | $2.37B | $18.2B |
| Net cash (debt) | ($6.73B) | ($56.2B) |
| 1-year price return | -48.5% | +19.8% |
| P/E | 11.8 | 77.4 |
| P/E vs own history (cheap-side %) | 97% | 23% |
| Dividend yield | 2.89% | 2.45% |
| Return on equity | 69% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 14,500 | 57,000 |
Full résumé-style profiles: ZTS CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.